Stay updated on Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Sign up to get notified when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-11-03T22:55:11.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the footer revision advances from v3.7.1 to v3.7.2. The study record itself remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:18:27.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from `v3.7.0` to `v3.7.1` on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:33:16.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content and documents. As a result, core study details and linked resources are no longer visible.
    Difference
    19%
    Check dated 2026-09-23T00:08:55.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new version of the page content.
    Difference
    0.0%
    Check dated 2026-09-16T00:31:25.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, signaling a newer version of the page content. This update changes only the version metadata and does not modify study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-09-01T20:58:56.000Z thumbnail image

Stay in the know with updates to Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.